Blueprint Medicines Corporation (NASDAQ:BPMC) previous close was $82.79 while the outstanding shares total 58.02M. The firm has a beta of 0.70, a 12-month trailing P/E
Blueprint Medicines Corporation (NASDAQ:BPMC) Relative Strength Index (RSI) is 37.99, with weekly volatility at 5.80% and ATR at 3.83. The BPMC stock’s 52-week price range
Blueprint Medicines Corporation (NASDAQ:BPMC) shares fell to a low of $83.99 before closing at $84.75. Intraday shares traded counted 1.86 million, which was -409.96% lower
Blueprint Medicines Corporation (NASDAQ:BPMC) shares fell to a low of $86.34 before closing at $87.13. Intraday shares traded counted 0.72 million, which was -91.76% lower
Blueprint Medicines Corporation (NASDAQ:BPMC) shares fell to a low of $92.92 before closing at $93.36. Intraday shares traded counted 0.43 million, which was -14.98% lower
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
